Upcoming Event: VacChina 2016 - Human/Veterinary Vaccine Forum
12/10/2015
Event: VacChina 2016 - Human/Veterinary Vaccine Forum
Dates: April 12 - 13, 2016
Venue: TBD, Shanghai, China
Contact: Constance Shen
Tel: +86 21 5242 8147
Exploring Big Opportunities for Vaccine Industry in China and Emerging Markets
China vaccine market expanded fast and has kept a leading growth during the past years. It is expected to reach more than USD 4 billion by 2016. Through multiple partnerships, a series of important novel vaccines including HFMD, Sabin IPV, HPV and EPV have been successfully developed. Besides, China is also embracing a gold period on therapeutic vaccine development. Following Chengdu Institute, Hualan has also got the approval of WHO PQ in early 2015. Leading companies like Sinovac, Zhifei Biotech are building their strategy for emerging markets. In order to become qualified international player, local companies are striving to upgrade manufacturing facilities and QMS, with unprecedented passion.
At the same time, animal vaccine industry also enjoys fast development during recent years. The mandated immune plan promotes the market expansion while the market-oriented vaccines become the main driver for industry growth. With an annual growth of 24%, the animal vaccine market will reach more than 2.5 b USD in 2016. The booming market encourages soaring investment on new production line both from local and international companies. Besides, technology transfer on novel vaccine development is still a key point for major companies to keep competitive in China. Leading companies like Jinyu are building facilities in Africa for international market expansion.
VacChina 2016, to be held on April 12-13, in Shanghai, China, is the largest international vaccine event in China, covering the entire value chain of the vaccine industry. Here, two parallel forums will be arranged on both human vaccine and animal vaccine, assessing the latest industrial trends, R&D progress, partnership opportunities and manufacturing technology advancements in China and Emerging markets. Meanwhile, Companies will also know the way to get into the emerging markets and build international partnership on vaccine development and commercialization as well.
Key issues for VacChina 2016
Human Vaccine Forum:
-
-
Building regional partnership to accelerate novel vaccine development
-
Building regional partnership to accelerate novel vaccine development
-
Successful R&D &Commercialization Strategy for vaccines
-
Integrating Chinese vaccine into global Market
-
Ebola/ MERS/HPV/RSV vaccine development update
-
Clinical strategies for Vaccines
-
Advanced technologies and strategies for excellent biomanufacturing
-
Adjuvant/Formulation technologies
Animal Vaccine Forum:
-
Strategies to development veterinary vaccine in China
-
Supply and demand of emerging vaccine markets
-
Technology transfer in global veterinary vaccine development
-
Catching big opportunities in global animal vaccine market through novel strategic partnership model
-
Regulatory Requirements for Conventional and Next Generation Veterinary Vaccines
-
Suspension culture and microcarrier culture techniques applied in animal vaccine manufacturing
-
Novel adjuvant technology in vaccine development
-
Recombined vaccine development